ADVPHARMA INC has a total of 19 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Taiwan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are SOLGENT CO, DENOVO BIOPHARMA LLC and INAZAWA JOHJI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Taiwan | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Terng Harn-Jing | 10 |
#2 | Chen Jeremy J W | 8 |
#3 | Yang Pan-Chyr | 6 |
#4 | Lee Woan-Jen | 6 |
#5 | Lee Yi-Jen | 5 |
#6 | Yu Sung-Liang | 4 |
#7 | Chou Yeh-Tze | 4 |
#8 | Chen Hsuan-Yu | 4 |
#9 | Chen Chin-Yu | 3 |
#10 | Terng Harn Jing | 3 |
Publication | Filing date | Title |
---|---|---|
EP2329040A2 | Molecular markers for lung and colorectal carcinomas | |
WO2008118350A1 | Compositions and methods of using crmp-1 and its fragments for treating cancer | |
US2006211036A1 | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients | |
TW200533759A | Collapsin response mediator protein-1 (crmp-1) tra | |
US7211660B2 | Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences | |
US7223792B2 | Cytotoxic annonaceous acetogenins from Annona muricata | |
TWI247009B | Annonaceous acetogenins having cytotoxic effect on tumor cells, its preparation method and medicinal composition thereof |